|
Statement
| 1.Date of occurrence of the event:2022/06/13
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of
$418,208 thousands(expressed in NT dollars; unaudited), a consolidated
operating profit of $123,061 thousands, and a consolidated income
before tax of $128,957 thousands in May 2022; net income attributed to
stockholders of the company was $102,847 thousands; EPS is $0.41.
Year-to-date consolidated net sales was $1,827,628 thousands (in NT
dollars; unaudited), a consolidated operating profit was $477,287
thousands and consolidated income before tax was $537,174 thousands
until May 2022; year-to-date net income attributed to stockholders
of the company was $427,476 thousands; EPS is $1.72.
6.Countermeasures:None.
7.Any other matters that need to be specified:The numbers above are unaudited.
In term of the final net sales and profits, quarterly financial reports
audited by independent accountants will prevail.
|
